EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of a non‐fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries‐susceptible orthodontic patients: A randomized, controlled 6‐month trial

Ulrich Schlagenhauf iD, Karl-Heinz Kunzelmann, Christian Hannig, Theodor W May, Helmut Hösl, Mario Gratza, Gabriele Viergutz, Marco Nazet, Sebastian Schamberger, Peter Proff

Journal of Investigative and Clinical Dentistry · 2019-05 · 10 (2)

DOI: 10.1111/jicd.12399 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Investigative and Clinical Dentistry, online erschienen am 30.01.2019. Verfasst von Ulrich Schlagenhauf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Conservative Dentistry and Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany. Hauptthemen laut MEDLINE: Dental Caries, Dentifrices. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of the present randomized, controlled trial was to compare the impact of the regular use of a fluoride‐free microcrystalline hydroxyapatite ( HAP ) dentifrice and a 1400 ppm fluoride control dentifrice on caries progression in 150 highly caries‐active orthodontic patients.

Methods

The primary outcome was the occurrence of lesions with International Caries Detection and Assessment System ( ICDAS ) ≥code 1 on the vestibular surfaces of teeth 15‐25 within 168 days after fixation of orthodontic brackets. Secondary outcomes were lesion development ICDAS ≥code 2, the plaque index, and the gingival index.

Results

In total, 147 patients were included in the intent‐to‐treat ( ITT ) analysis; 133 finished the study per protocol ( PP ). An increase in enamel caries ICDAS ≥code 1 was observed in 56.8% ( ITT ) and 54.7% ( PP ) of the HAP group participants compared with 60.9% ( ITT ) and 61.6% ( PP ) of the fluoride control group. Non‐inferiority testing ( ITT and PP ) demonstrated the absence of a significant difference between the groups. No significant differences in secondary outcomes were observed between the groups.

Conclusion

In highly caries‐active patients, the impact of the regular use of a microcrystalline HAP dentifrice on caries progression is not significantly different from the use of a 1400 ppm fluoride toothpaste (ClinicalTrials.gov: NCT 02705456).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dental CariesDentifricesCariostatic AgentsFluoridesHumansHydroxyapatitesToothpastes

Stichwörter der Autor:innen

dentifriceenamel cariesfluoridehydroxyapatiteorthodontic therapy

Substanzen

Cariostatic AgentsDentifricesHydroxyapatitesToothpastesFluorides

Autor:innen und Institutionen

  • Department of Conservative Dentistry and Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany.
  • Department of Conservative Dentistry and Periodontology, Ludwig-Maximilians-University, Munich, Germany.
  • Clinic of Operative and Pediatric Dentistry, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Society for Biometry and Psychometry, Bielefeld, Germany.
  • Department of Orthodontics, University Hospital Regensburg, Regensburg, Germany.
  • Department of Orthodontics, University Hospital Wuerzburg, Wuerzburg, Germany.

ORCID-Profile: Ulrich Schlagenhauf

Förderung

  • Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany

Zitieren

APA

Schlagenhauf, U., Kunzelmann, K. H., Hannig, C., May, T. W., Hösl, H., Gratza, M., Viergutz, G., Nazet, M., Schamberger, S., & Proff, P. (2019). Impact of a non‐fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries‐susceptible orthodontic patients: A randomized, controlled 6‐month trial. Journal of Investigative and Clinical Dentistry, 10(2). https://doi.org/10.1111/jicd.12399

Vancouver

Schlagenhauf U, Kunzelmann KH, Hannig C, May TW, Hösl H, Gratza M, et al. Impact of a non‐fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries‐susceptible orthodontic patients: A randomized, controlled 6‐month trial. Journal of Investigative and Clinical Dentistry. 2019;10(2). doi:10.1111/jicd.12399

BibTeX
@article{Schlagenhauf2019,
  author = {Schlagenhauf, Ulrich and Kunzelmann, Karl-Heinz and Hannig, Christian and May, Theodor W and Hösl, Helmut and Gratza, Mario and Viergutz, Gabriele and Nazet, Marco and Schamberger, Sebastian and Proff, Peter},
  title = {Impact of a non‐fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries‐susceptible orthodontic patients: A randomized, controlled 6‐month trial},
  journal = {Journal of Investigative and Clinical Dentistry},
  year = {2019},
  volume = {10},
  number = {2},
  doi = {10.1111/jicd.12399}
}
Kostenlos starten →